Aung Zaw Lin, DO
Infectious Disease · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 3 carriers
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: 757662 · El Camino Health. That is not proof they admit you there this week.
Plans that list them
3 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lin’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$50,180
Medicare paid this office $50,180 for 183 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $16,389 | $101 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $11,367 | $140 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $6,304 | $66 |
| Long return visit (40+ min) | 26 | $5,646 | $166 |
| New patient visit (60+ min) | 14 | $2,805 | $200 |
See all 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $16,389 | $101 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $11,367 | $140 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $6,304 | $66 |
| Long return visit (40+ min) | 26 | $5,646 | $166 |
| New patient visit (60+ min) | 14 | $2,805 | $200 |
| Return visit (30+ min) | 19 | $2,224 | $111 |
| Telephone or internet assessment with verbal and written report by consulting physician, 11-20 minutes | 11 | $238 | $22 |
Who their Medicare patients are
183 Original Medicare patients in 2024. Average age 77 · Under 65 10% · 85 and older 27% · Women 55% · Also on Medicaid 33% · Health risk score 3.01. Above the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Diabetes 56% · Chronic kidney disease 51% · Coronary heart disease 49% · Heart failure 43% · Depression 39% · Atrial fibrillation 38% · COPD 30% · Dementia 28% · Cancer 23% · Stroke 21%.
The office billed $305,272, Medicare allowed $64,391 and paid $50,180; for 481 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 183 | 481 | 77 | 3.01 | $305,272 | $50,180 |
| 2023 | 115 | 373 | 76 | 2.44 | $275,768 | $36,502 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $12,960 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $7,846 | $145 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $4,905 | $66 |
| New patient visit (60+ min) | 16 | $3,015 | $188 |
| Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | 12 | $460 | $26 |
| Telephone or internet assessment with verbal and written report by consulting physician, 11-20 minutes | 13 | $386 | $30 |
Drugs they prescribed that Part D paid
$116,391
Pharmacies billed $116,391 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 96) in 2024. At or below the middle of the specialty; the typical infectious disease clinician is at 0%.
81 generic and 15 brand-name prescriptions · $116,391 in drug cost · 60 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vancomycin | 13 | $1,459 | $112 |
| Ceftriaxone | 12 | $253 | $21 |
Year by year
| 2024 | 96 | 29 | 0% (0) | 16% | $116,391 |
| 2023 | 275 | 27 | 0% (0) | None | $253,133 |
| 2022 | 321 | 21 | 0% (0) | 34% | $257,137 |
| 2021 | 106 | 38 | None | None | $32,826 |
| 2020 | 178 | 65 | None | None | $9,457 |
| 2019 | 242 | 76 | 0% (0) | None | $11,329 |
| 2018 | 115 | 59 | 0% (0) | None | $5,381 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Biktarvy | 16 | $58,692 | $3,668 |
| Tivicay | 15 | $35,057 | $2,337 |
| Descovy | 13 | $30,840 | $2,372 |
| Fluconazole | 17 | $2,305 | $136 |
| Atorvastatin | 15 | $351 | $23 |
| Rosuvastatin | 11 | $304 | $28 |
| Benazepril | 11 | $228 | $21 |
| Omeprazole | 13 | $220 | $17 |
| Amlodipine Besylate | 16 | $199 | $12 |
2022: 12 drugs
| Triumeq | 19 | $69,221 | $3,643 |
| Tivicay | 21 | $44,197 | $2,105 |
| Dovato | 11 | $31,508 | $2,864 |
| Descovy | 12 | $25,260 | $2,105 |
| Cefepime | 12 | $6,641 | $553 |
| Lamivudine | 13 | $725 | $56 |
| Fluconazole | 12 | $635 | $53 |
| Albuterol Sulfate Hfa | 11 | $339 | $31 |
| Omeprazole | 15 | $240 | $16 |
| Atorvastatin | 26 | $200 | $8 |
| Amlodipine Besylate | 25 | $39 | $2 |
| Famotidine | 12 | $24 | $2 |
2021: 1 drug
| Atorvastatin | 11 | $106 | $10 |
2020: 1 drug
| Amlodipine Besylate | 13 | $131 | $10 |
2019: 4 drugs
| Atorvastatin | 13 | $303 | $23 |
| Lisinopril | 14 | $162 | $12 |
| Amlodipine Besylate | 14 | $127 | $9 |
| Metoprolol | 13 | $108 | $8 |
Money from drug and device companies
$353 in 2025
A payment is not proof that care is biased.
| Abbott Laboratories | Amplatzer Amulet | $200 | 1 payment
|
| Cordis US | Mynx Control Venous | $89 | 1 payment
|
| Gilead Sciences | None | $36 | 2 payments
|
| Paratek Pharmaceuticals | Nuzyra | $27 | 1 payment
|
See all 5 published payments
| Paratek Pharmaceuticals | Meals · 2025-09-29 | Nuzyra | $27 |
| Gilead Sciences | Meals · 2025-08-06 | None | $21 |
| Gilead Sciences | Meals · 2025-07-07 | None | $16 |
| Cordis US | Meals · 2025-04-28 | Mynx Control Venous | $89 |
| Abbott Laboratories | Meals · 2025-03-14 | Amplatzer Amulet | $200 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 86.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1124521935
- Licence
- CA 20A17768
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2018-03-18
- NPI last updated
- 2024-08-27
- NPI record certified
- 2024-08-27
This is when the NPI record was last certified, not a medical board exam.